RMD

Resmed Inc (RMD)

Stock Code

RMD

Stock Exchange

Australian Securities Exchange

ResMed Inc. (RMD) is a specialist medical device manufacturer principally focused on the development, manufacturing and sale of medical equipment for the treatment and diagnosis of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) together with other respiratory disorders occurring during sleep. ResMed Inc is listed on two stock exchanges, the NYSE and the ASX. It listed on the Australian Stock Exchange (ASX) on 25th of November, 1999. The Company employs circa 2000 people worldwide. ResMed Inc.

2012's First Week of the Best and Worst Traded Stocks


The holidays are over and companies are back in business to face the new year for the rollercoaster ride of share prices. The lists below are a record of the best and worst traded stocks in the ASX100, ASX200 and All Ordinaries in the Australian Securities Exchange in the first week of 2012, January 2-6, 2012.

Best Performing Trade Stocks ASX100 (XTO)

ASX100

AGM's for Thursday


There are no floats scheduled but there are two upcoming ex-dividend and several Annual General Meetings listed in the stock market events tomorrow, November 17, 2011.

Ex-Dividends

Best Australian Sharemarket Shares - ASX 100


Best Australian Sharemarket Shares on the ASX 100 for the week. These stocks increased their share price by the largest percentage on the Australian sharemarket, the Australian Securities Exchange (ASX) from the previous week of trading (9th week: 28th February to 4th March 2011). Other lists of ASX companies by market capitalisation.

ASX 100 Stock Picks Which Rocked


ASX 100 stock picks which rocked last week. These stocks increased their share price by the biggest percentage on the Australian stockmarket, the Australian Securities Exchange (ASX) from the last week of trading (45th week of 2010 including the business days of 8th to 12th November). Stocks in this list: ILU, AWE, CQO, PDN, TEL, RMD, IPL, PRY, OST, RIV, OZL, SKI, TEN, AXA, STO.

ResMed Inc. Dividends

1 September, 2010 - 12:29

Study the dividend history for RESMED INC. Dividends are a portion of company profits paid out to shareholders. You are eligible to receive RMD dividends if you own the RESMED INC shares on the ex-dividend date. Traders and investors must purchase the stock before the exdividend date to be entitled to the dividend. The previous owner of the shares will receive the RMD dividend if you buy the stocks on or after the ex dividend date.

Low Performing Australian Shares - ASX 100


Low Performing Australian Shares from the ASX 100 index. These stocks decreased their share price by the most percentage points on the Australian share market, the Australian Securities Exchange (ASX) from the previous week of trading. Other lists of Australian companies by Market capitalisation.

List of Low Performing Australian Shares - ASX 100

Eldorado Gold Corporation- Winner of the Week


Eldorado Gold Corporation (EAU), a company that produces gold through projects in Brazil, China, Greece, Turkey and surrounding regions was the best performer of the 17th week in ASX200 with a gain of 9.4 percent closing the week at $18.06 (market capitalisation $548.5 million). The company traded its stocks for $16.51 last week.

Week 13 Worst Performers


Incitec Pivot (IPL), an Australian global chemical company that mainly focuses on the production, trading and supply of fertilizers and chemicals was the worst performer of the ASX100 list for the 13th week of 2010. The company had a market capitalisation of $5378.5 million and lost 4.6 percent or 16 cents to its stock price closing for the week at $3.31.

Private Equity Firms: What Might They Pay?


Following the recent spate of attempts by private equity (PE) firms to take over listed entities, Macquarie Research Equities (MRE) have investigated which top 100 stocks have the balance sheet capacity to be re-geared, and what a PE firm could pay as a full price. The aim of this analysis was to gauge what would be the full takeover valuation price a PE firm could pay. This is given the current willingness to re-gear balance sheets and the extremely low risk premium being applied by PE investors to equities and debt at present.

Syndicate content